YU71489A - New substituted azetidinones as anti-inflammatoric and antidegenerative agents - Google Patents
New substituted azetidinones as anti-inflammatoric and antidegenerative agentsInfo
- Publication number
- YU71489A YU71489A YU00714/89A YU71489A YU71489A YU 71489 A YU71489 A YU 71489A YU 00714/89 A YU00714/89 A YU 00714/89A YU 71489 A YU71489 A YU 71489A YU 71489 A YU71489 A YU 71489A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- inflammatoric
- new substituted
- substituted azetidinones
- antidegenerative agents
- antidegenerative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Reinforced Plastic Materials (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17968888A | 1988-04-11 | 1988-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU71489A true YU71489A (en) | 1991-10-31 |
Family
ID=22657566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU00714/89A YU71489A (en) | 1988-04-11 | 1989-04-10 | New substituted azetidinones as anti-inflammatoric and antidegenerative agents |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0337549B1 (fr) |
JP (1) | JP2736113B2 (fr) |
KR (1) | KR930008223B1 (fr) |
CN (1) | CN1037144A (fr) |
AT (1) | ATE128704T1 (fr) |
AU (1) | AU621865B2 (fr) |
CA (1) | CA1337990C (fr) |
DE (1) | DE68924439T2 (fr) |
DK (1) | DK169329B1 (fr) |
ES (1) | ES2079373T3 (fr) |
FI (1) | FI891689A (fr) |
GR (1) | GR3017656T3 (fr) |
HU (1) | HUT50761A (fr) |
IE (1) | IE891140L (fr) |
IL (1) | IL89835A0 (fr) |
LV (1) | LV11459B (fr) |
NO (1) | NO891470L (fr) |
NZ (1) | NZ228600A (fr) |
PT (1) | PT90222B (fr) |
YU (1) | YU71489A (fr) |
ZA (1) | ZA892549B (fr) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229510A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | β-lactams useful in determining the amount of elastase in a clinical sample |
US5229381A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
GB9103654D0 (en) * | 1991-02-21 | 1991-04-10 | Merck Sharp & Dohme | Chemical process |
US5100880A (en) * | 1991-03-20 | 1992-03-31 | Merck & Co., Inc. | Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
US5104862A (en) * | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
EP0533951A4 (en) * | 1991-04-10 | 1993-09-01 | Japan Tobacco Inc. | Novel oxazinone derivative |
US5348953A (en) * | 1991-06-25 | 1994-09-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
WO1993000332A1 (fr) * | 1991-06-25 | 1993-01-07 | Merck & Co., Inc. | Azetidinones substituees utilisees comme agents antiinflammatoires et antidegeneratifs |
US5688785A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
US5688787A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof |
TW223059B (fr) * | 1991-07-23 | 1994-05-01 | Schering Corp | |
EP0529719A1 (fr) * | 1991-08-26 | 1993-03-03 | Merck & Co. Inc. | Essai pour évaluer l'inhibition de PMN élastase par azétidinones N-substitués |
US5229267A (en) * | 1991-08-26 | 1993-07-20 | Merck & Co., Inc. | Assay for evaluating inhibition of PMN elastase by N-substituted azetidinones |
US5276139A (en) * | 1991-08-26 | 1994-01-04 | Merck & Co., Inc. | Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones |
US5274080A (en) * | 1991-08-26 | 1993-12-28 | Merck & Co., Inc. | Monospecific antibodies useful in evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones |
US5149838A (en) * | 1991-09-20 | 1992-09-22 | Merck & Co., Inc. | Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents |
GB2266527A (en) * | 1992-03-17 | 1993-11-03 | Merck & Co Inc | Substituted azetidinones useful in the treatment of leukemia |
US5250676A (en) * | 1992-03-23 | 1993-10-05 | University Of Notre Dame Du Lac | Process for the preparation of 3-substituted-2-azetidinones |
CA2147129A1 (fr) * | 1992-10-27 | 1994-05-11 | James B. Doherty | Nouvelles azetidinones substituees utilisees comme agents anti-inflammatoires et anti-degeneratifs |
TW275621B (fr) * | 1992-10-27 | 1996-05-11 | Merck & Co Inc | |
US5591737A (en) * | 1992-12-17 | 1997-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
AU5802894A (en) * | 1992-12-17 | 1994-07-04 | Merck & Co., Inc. | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
LT3595B (en) | 1993-01-21 | 1995-12-27 | Schering Corp | Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
GB9314350D0 (en) * | 1993-07-12 | 1993-08-25 | Zeneca Ltd | Armide derivatives |
US5420010A (en) * | 1993-07-30 | 1995-05-30 | Merck & Co., Inc. | Assay for evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones |
US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5403952A (en) * | 1993-10-08 | 1995-04-04 | Merck & Co., Inc. | Substituted cyclic derivatives as novel antidegenerative agents |
EP0755262A4 (fr) * | 1994-03-11 | 1997-05-07 | Merck & Co Inc | Composition de traitement de pneumopathie |
US5627176A (en) * | 1994-03-25 | 1997-05-06 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
US5633246A (en) * | 1994-11-18 | 1997-05-27 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5624920A (en) * | 1994-11-18 | 1997-04-29 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
US5656624A (en) * | 1994-12-21 | 1997-08-12 | Schering Corporation | 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
WO1996029307A1 (fr) * | 1995-03-23 | 1996-09-26 | Japan Tobacco Inc. | Composes de diphenylmethyle-azetidinone et inhibiteur d'elastase |
US5747485A (en) * | 1995-04-13 | 1998-05-05 | Merck & Co., Inc. | Substituted azetidiones as anti-inflammatory and antidegenerative agents |
US5523233A (en) * | 1995-05-03 | 1996-06-04 | Merck & Co., Inc. | Enzymatic hydrolysis of 3,3-diethyl-4-[(4-carboxy)phenoxy]-2-azetidinone esters |
AP728A (en) * | 1995-07-01 | 1999-01-29 | Smithkline Beecham Plc | Azetidinone derivatives for the treatment of atherosclerosis. |
WO1997013750A1 (fr) * | 1995-10-09 | 1997-04-17 | Chiroscience Limited | Azetidinones et leur utilisation therapeutique en tant qu'inhibiteurs des cytokines |
EP0869943A1 (fr) * | 1995-12-08 | 1998-10-14 | Smithkline Beecham Plc | Derives de beta-lactame monocycliques utilises dans le traitement de l'atherosclerose |
HUP9901359A3 (en) * | 1996-04-26 | 2000-03-28 | Smithkline Beecham Plc | Azetidinone derivatives for the treatment of atherosclerosis, process for their producing and pharmaceutical compositions containing them |
US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
EP1021405B1 (fr) * | 1997-10-07 | 2002-09-25 | Boehringer Ingelheim (Canada) Ltd. | Derives d'azetidinone pour le traitement d'infections hcmv |
JP2001519328A (ja) * | 1997-10-07 | 2001-10-23 | ベーリンガー インゲルハイム (カナダ) リミテッド | Hcmv感染症治療のためのアゼチジノン誘導体 |
DK1023265T3 (da) * | 1997-10-07 | 2003-02-24 | Boehringer Ingelheim Ca Ltd | Azetidinonderivater til behandlingen af HCMV infektioner |
WO1999064395A1 (fr) * | 1998-06-11 | 1999-12-16 | Merck & Co., Inc. | Composes d'amide heterocycliques utilises comme inhibiteurs d'adhesion cellulaire |
US6335324B1 (en) | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
WO2000005204A1 (fr) * | 1998-07-23 | 2000-02-03 | Shionogi & Co., Ltd. | COMPOSES DE β-LACTAME MONOCYCLIQUES ET INHIBITEURS DE LA CHYMASE LES RENFERMANT |
US6593078B1 (en) | 1999-04-16 | 2003-07-15 | Schering Corporation | Use of azetidinone compounds |
DE60206365T2 (de) | 2001-03-28 | 2006-07-06 | Schering Corporation, Kenilworth | Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
DE602004016123D1 (de) | 2003-03-07 | 2008-10-09 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
ATE418551T1 (de) | 2003-03-07 | 2009-01-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
US8440819B2 (en) * | 2008-02-22 | 2013-05-14 | Allergan, Inc. | Therapeutic substituted beta-lactams |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680391A (en) * | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
-
1989
- 1989-04-04 IL IL89835A patent/IL89835A0/xx unknown
- 1989-04-04 NZ NZ228600A patent/NZ228600A/en unknown
- 1989-04-06 ES ES89200864T patent/ES2079373T3/es not_active Expired - Lifetime
- 1989-04-06 DE DE68924439T patent/DE68924439T2/de not_active Expired - Fee Related
- 1989-04-06 EP EP89200864A patent/EP0337549B1/fr not_active Expired - Lifetime
- 1989-04-06 AT AT89200864T patent/ATE128704T1/de not_active IP Right Cessation
- 1989-04-07 ZA ZA892549A patent/ZA892549B/xx unknown
- 1989-04-07 CA CA000595997A patent/CA1337990C/fr not_active Expired - Fee Related
- 1989-04-07 PT PT90222A patent/PT90222B/pt not_active IP Right Cessation
- 1989-04-10 YU YU00714/89A patent/YU71489A/xx unknown
- 1989-04-10 AU AU32630/89A patent/AU621865B2/en not_active Ceased
- 1989-04-10 DK DK170589A patent/DK169329B1/da not_active IP Right Cessation
- 1989-04-10 IE IE891140A patent/IE891140L/xx not_active IP Right Cessation
- 1989-04-10 CN CN89103271A patent/CN1037144A/zh active Pending
- 1989-04-10 FI FI891689A patent/FI891689A/fi not_active Application Discontinuation
- 1989-04-10 NO NO89891470A patent/NO891470L/no unknown
- 1989-04-10 KR KR1019890004702A patent/KR930008223B1/ko active IP Right Grant
- 1989-04-10 HU HU891708A patent/HUT50761A/hu unknown
- 1989-04-11 JP JP1091723A patent/JP2736113B2/ja not_active Expired - Fee Related
-
1995
- 1995-10-05 GR GR950402512T patent/GR3017656T3/el unknown
-
1996
- 1996-02-01 LV LVP-96-24A patent/LV11459B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU621865B2 (en) | 1992-03-26 |
NO891470D0 (no) | 1989-04-10 |
IE891140L (en) | 1989-10-11 |
LV11459B (en) | 1996-12-20 |
LV11459A (lv) | 1996-08-20 |
ES2079373T3 (es) | 1996-01-16 |
AU3263089A (en) | 1989-10-12 |
DK169329B1 (da) | 1994-10-10 |
ZA892549B (en) | 1989-11-29 |
KR930008223B1 (ko) | 1993-08-27 |
CN1037144A (zh) | 1989-11-15 |
KR900016121A (ko) | 1990-11-12 |
FI891689A0 (fi) | 1989-04-10 |
NO891470L (no) | 1989-10-12 |
HUT50761A (en) | 1990-03-28 |
NZ228600A (en) | 1992-02-25 |
PT90222B (pt) | 1994-07-29 |
IL89835A0 (en) | 1989-12-15 |
PT90222A (pt) | 1989-11-10 |
JP2736113B2 (ja) | 1998-04-02 |
FI891689A (fi) | 1989-10-12 |
JPH026471A (ja) | 1990-01-10 |
GR3017656T3 (en) | 1996-01-31 |
DK170589D0 (da) | 1989-04-10 |
CA1337990C (fr) | 1996-01-23 |
EP0337549A1 (fr) | 1989-10-18 |
DE68924439T2 (de) | 1996-05-09 |
EP0337549B1 (fr) | 1995-10-04 |
DK170589A (da) | 1989-10-12 |
DE68924439D1 (de) | 1995-11-09 |
ATE128704T1 (de) | 1995-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3017656T3 (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents. | |
ES553821A0 (es) | Un procedimiento para la preparacion de nuevas azetidinonas sustituidas. | |
AU8583391A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
ZA878467B (en) | New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents | |
MY128261A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
DE68927221T2 (de) | Schmierverfahren und Zusammensetzung dafür | |
ES2042726T3 (es) | Beta-alquilmelatoninas. | |
AU3120489A (en) | 2-oxo-3-(substituted aminocarbonyl) indoles as anti-inflammatory agents | |
AU5587594A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
BR8506797A (pt) | Composicoes combustiveis | |
ZA854947B (en) | Beta-lactam derivatives as anti-inflammatory and anti-degenerative agents | |
IT1217237B (it) | Torretta portautensili rotante | |
EP0505097A3 (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
ZA937949B (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
KR940014984U (ko) | 공작용 톱 | |
BR8900135A (pt) | Composicao anaerobia | |
KR890022646U (ko) | 너트 탭핑기 (Tapping machine) | |
DE4392367T1 (de) | Verbesserungen bei der oder betreffend die Züchtung von Nadelbäumen | |
ZA895521B (en) | Work stage | |
DK656288D0 (da) | Spaendevaerktoej, saasom en skruestik | |
KR900011870A (ko) | 혐기성 조성물 |